JPWO2018204661A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2018204661A5 JPWO2018204661A5 JP2019560299A JP2019560299A JPWO2018204661A5 JP WO2018204661 A5 JPWO2018204661 A5 JP WO2018204661A5 JP 2019560299 A JP2019560299 A JP 2019560299A JP 2019560299 A JP2019560299 A JP 2019560299A JP WO2018204661 A5 JPWO2018204661 A5 JP WO2018204661A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- pharmaceutically acceptable
- solvate
- hydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762502391P | 2017-05-05 | 2017-05-05 | |
| US62/502,391 | 2017-05-05 | ||
| US201862624273P | 2018-01-31 | 2018-01-31 | |
| US62/624,273 | 2018-01-31 | ||
| PCT/US2018/030909 WO2018204661A1 (en) | 2017-05-05 | 2018-05-03 | Quinazoline-pyridine derivatives for the treatment of cancer-related disorders |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020518627A JP2020518627A (ja) | 2020-06-25 |
| JP2020518627A5 JP2020518627A5 (ru) | 2021-07-26 |
| JPWO2018204661A5 true JPWO2018204661A5 (ru) | 2022-08-12 |
| JP7295034B2 JP7295034B2 (ja) | 2023-06-20 |
Family
ID=64016681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560299A Active JP7295034B2 (ja) | 2017-05-05 | 2018-05-03 | 癌関連障害の治療のためのキナゾリン－ピリジン誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11045472B2 (ru) |
| EP (1) | EP3618829B1 (ru) |
| JP (1) | JP7295034B2 (ru) |
| CN (1) | CN110612100B (ru) |
| ES (1) | ES2953349T3 (ru) |
| PL (1) | PL3618829T3 (ru) |
| TW (1) | TWI789393B (ru) |
| UY (1) | UY37725A (ru) |
| WO (1) | WO2018204661A1 (ru) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2951809T3 (es) * | 2017-05-17 | 2023-10-25 | Arcus Biosciences Inc | Derivados de quinazolina-pirazol para el tratamiento de trastornos relacionados con el cáncer |
| CN109293586A (zh) * | 2018-11-22 | 2019-02-01 | 云南师范大学 | 一种在氨水中微波条件下卤代苯甲酸合成喹唑啉酮化合物的方法 |
| WO2020146563A1 (en) * | 2019-01-10 | 2020-07-16 | Dana-Farber Cancer Institute, Inc. | Modulating biomarkers such as spp to increase tumor immunity and improve the efficacy of cancer immunotherapy |
| IL295569A (en) | 2020-03-19 | 2022-10-01 | Arcus Biosciences Inc | Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha |
| PE20231078A1 (es) | 2020-06-02 | 2023-07-17 | Arcus Biosciences Inc | Anticuerpos anti-tigit |
| US11649261B2 (en) | 2020-06-17 | 2023-05-16 | Arcus Biosciences, Inc. | Crystalline forms of a CD73 inhibitor and uses thereof |
| US11814364B2 (en) | 2021-03-18 | 2023-11-14 | Janssen Pharmaceutica Nv | Pyridine N-oxide derivatives useful as factor XIa inhibitors |
| US11845748B2 (en) | 2021-03-18 | 2023-12-19 | Janssen Pharmaceutica Nv | Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitors |
| US11919881B2 (en) | 2021-03-18 | 2024-03-05 | Janssen Pharmaceutica Nv | Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitors |
| EP4341262A1 (en) | 2021-05-21 | 2024-03-27 | Arcus Biosciences, Inc. | Axl inhibitor compounds |
| WO2022246177A1 (en) | 2021-05-21 | 2022-11-24 | Arcus Biosciences, Inc. | Axl compounds |
| EP4423069A1 (en) | 2021-10-29 | 2024-09-04 | Arcus Biosciences, Inc. | Inhibitors of hif-2alpha and methods of use thereof |
| WO2023215719A1 (en) | 2022-05-02 | 2023-11-09 | Arcus Biosciences, Inc. | Anti-tigit antibodies and uses of the same |
| US20240124490A1 (en) | 2022-07-15 | 2024-04-18 | Arcus Biosciences, Inc. | Inhibitors of hpk1 and methods of use thereof |
| WO2024020034A1 (en) | 2022-07-20 | 2024-01-25 | Arcus Biosciences, Inc. | Cbl-b inhibitors and methods of use thereof |
| WO2024081385A1 (en) | 2022-10-14 | 2024-04-18 | Arcus Biosciences, Inc. | Hpk1 inhibitors and methods of use thereof |
| US20240180947A1 (en) | 2022-10-20 | 2024-06-06 | Arcus Biosciences, Inc. | Lyophilized formulations of cd73 compounds |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1397364T3 (da) * | 2001-05-24 | 2007-11-26 | Lilly Co Eli | Hidtil ukendte pyrrolderivater som farmaceutiske midler |
| TWI330183B (ru) | 2001-10-22 | 2010-09-11 | Eisai R&D Man Co Ltd | |
| ES2311759T3 (es) * | 2003-05-06 | 2009-02-16 | Cv Therapeutics, Inc. | Derivados de xantina como antagonistas del receptor a2b de adenosina. |
| BRPI0417478A (pt) * | 2003-12-15 | 2007-05-08 | Almirall Prodesfarma Ag | 2,6-bis-heteroaril-4-aminopirimidinas como antagonistas de receptor de adenosina |
| TW200813056A (en) * | 2006-06-29 | 2008-03-16 | King Pharmaceuticals Res Dev Inc | Adenosine A2B receptor antagonists |
| TWI473614B (zh) * | 2008-05-29 | 2015-02-21 | Kyowa Hakko Kirin Co Ltd | Anti-analgesic inhibitors |
| WO2010033906A2 (en) * | 2008-09-19 | 2010-03-25 | President And Fellows Of Harvard College | Efficient induction of pluripotent stem cells using small molecule compounds |
| EP2210891A1 (en) * | 2009-01-26 | 2010-07-28 | Domain Therapeutics | New adenosine receptor ligands and uses thereof |
| US8871744B2 (en) | 2010-07-21 | 2014-10-28 | B & G Partyers, LLC | Compounds and methods for selectively targeting tumor-associated mucins |
| WO2016126570A1 (en) * | 2015-02-06 | 2016-08-11 | Merck Sharp & Dohme Corp. | Aminoquinazoline compounds as a2a antagonist |
-
2018
- 2018-05-03 CN CN201880029680.6A patent/CN110612100B/zh active Active
- 2018-05-03 ES ES18794742T patent/ES2953349T3/es active Active
- 2018-05-03 EP EP18794742.9A patent/EP3618829B1/en active Active
- 2018-05-03 JP JP2019560299A patent/JP7295034B2/ja active Active
- 2018-05-03 US US16/610,812 patent/US11045472B2/en active Active
- 2018-05-03 WO PCT/US2018/030909 patent/WO2018204661A1/en active Application Filing
- 2018-05-03 PL PL18794742.9T patent/PL3618829T3/pl unknown
- 2018-05-04 UY UY0001037725A patent/UY37725A/es not_active Application Discontinuation
- 2018-05-04 TW TW107115270A patent/TWI789393B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2018204661A5 (ru) | ||
| JP2020519664A5 (ru) | ||
| JP2019529500A5 (ru) | ||
| JP2019501223A5 (ru) | ||
| HRP20231157T1 (hr) | Azolopirimidin za liječenje poremećaja povezanih s rakom | |
| Ruiz et al. | New palladium (II) and platinum (II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA | |
| Dada et al. | Synthesis and anticancer activity of novel NHC-gold (I)-sugar complexes | |
| JP2019511565A5 (ru) | ||
| JP2020518627A5 (ru) | ||
| AU2010290199B2 (en) | Kinase inhibitors, prodrug forms thereof and their use in therapy | |
| JP2011511095A5 (ru) | ||
| JP2013536870A (ja) | Ｎａｍｐｔの阻害のための新規化合物及び組成物 | |
| JP2016503414A5 (ru) | ||
| RU2014127753A (ru) | Ингибиторы пути передачи сигнала notch и их применение при лечении рака | |
| CA2736177A1 (en) | Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases | |
| TW202003507A (zh) | 具有四氫吡喃基甲基之吡啶酮衍生物及其用途 | |
| Jeannin et al. | Chalcogen bonding interactions in organic selenocyanates: from cooperativity to chelation | |
| JP2008516989A (ja) | 組成物及び抗腫瘍剤としてのその使用 | |
| BR112020011558A2 (pt) | Novos derivados de benzamida como moduladores do ppar-gama | |
| CY1109607T1 (el) | Παραγωγο εποθιλονης για τη θεραπευτικη αντιμετωπιση του ηπατωματος και αλλων κακοηθων νοσων | |
| JPWO2020023846A5 (ru) | ||
| Faihan et al. | Novel base-free dianion complexes of Pt (II) and Pd (II) derived from heterocyclic thiourea and tertiary phosphine ligands | |
| JPWO2018213377A5 (ru) | ||
| JPWO2020102646A5 (ru) | ||
| Swaminathan et al. | Hinged bipodal furoylthiourea-based Ru (II)-arene complexes: Effect of (ortho, meta, or para)-substitution on coordination and anticancer activity |